Coinsguy asked the following question to WW. Many will not

New Post Public Reply Private Reply Replies (1) Message Board
StevenRisk
211
Coinsguy asked the following question to WW. Many will not be happy with my candid response. They need a CFO who can actually broker these deals period instead of asking later WTF happened. Still believe in the dream but really?

1) Any news on the equipment certification? I thought we would have surely heard something by now.
2) Have the two notes payable issued in March for $250K been converted to shares? If so, might that explain the constant drop in share price as they recoup their investment?

Comments Regarding Questions 1&2.

!) Nothing to say as these note holders have the right to cash in after 6 months. Read the Q3 financials and they clearly can do this. It is much easier to make money at the bottom than on top. Do the math as I did with the 15 day and 20 day per the Q3 10Q at .52.

After 6 months using .0052 pre R/S
At .0052 x.65 (discount)=.00338
250,000 x .08=20,000 x.5(6 months)=$10,000 interest
250k( notes convertible)+$10k=$260,000
$260,000 /.00338=76,923,076 shares/RS(1/100)=769231
769231x.52=$400,000=$150K for 6 months

After 9 months assuming a 15 & 20 day low let's say equipment certification comes through and the low is .80

.008x .65(discount)=.0052
250,000 x .08=20000x.75(9/12 of a year =$15k interest
250K(notes converible)+$15K interest=$265K
$265K/.0052=50,961,538 shares/RS(1/100)=509,615
$509,615 x.80=$407,692-250,000=$157,692

There you have it to hold for an addition 3 months equals $7k. Remember when these deals were brokered the stock PPS was over .025= which equals $2.50+ a share. Makes management look like imbeciles considering the conversion here is possibly more than 75% lower plus the fact they discounted. I would not comment either if I were management. Time for a shake-up or wake the fuk-up!

2. With my answer to #1 which management is well aware of it is easiar to act like an ostrich and stick head in ground and own up and say this will stop. Instead say nothing and not comment. What is more incompetent the fact that you did this and how it harmed shareholders or wishing it away and not competent? Nuff said! These toxic financiers are pieces of crap and at the extent of expansion they must stop using it as management will piss away their majority ownership unless they give themselves free shares for job sell done. What a dilemma.




EVIO Inc (EVIO) Stock Research Links

EVIO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Emerging Leaders in Food Safety for 2024

Updated Category News Views 77

Celebrating the Rising Stars in Food Safety The Alliance to Stop Foodborne Illness is excited to recognize a distinguished group of skilled food safety professionals this year. They have unveiled the 2024 Class of 40 Under 40 Food Safety Professionals, highlighting those who are making impactful contributions to improve food safety practices. Each individual in this group...

Continue Reading
NIP Group Inc. Expands Horizons with New Game Publishing Division

Updated Category News Views 79

NIP Group Inc. Launches New Game Publishing Division Esports Powerhouse Expands into Game Development Industry Veteran Allen Sui at the Helm NIP Group Inc. (NASDAQ: NIPG), a key player in the digital entertainment industry, has officially revealed its entry into the game publishing sector. This strategic move marks a significant milestone in the company's journey to build...

Continue Reading
LogicMonitor Partners with OpenAI to Enhance ITOps Efficiency

Updated Category News Views 282

Transforming IT Operations with AI The collaboration between LogicMonitor and OpenAI is set to revolutionize IT operations, empowering organizations with cutting-edge technologies that enhance productivity and operational efficiency. By harnessing the power of AI, LogicMonitor aims to address the challenges faced by modern IT teams. Integrating Advanced AI Technologies...

Continue Reading
CordenPharma's Major Investment in Peptide Manufacturing Expansion

Updated Category News Views 454

Expansion of Peptide Manufacturing Facilities CordenPharma is embarking on a monumental journey with an investment exceeding €1 billion in the next three years. This ambitious plan encompasses the construction and expansion of various peptide manufacturing facilities across Europe and the US, reinforcing its commitment to innovation in peptide development. Investment in...

Continue Reading
Strategizing Small Cap Trades With Upcoming Fed Rate Cuts

Updated Category News Views 109

The FOMC Meeting and Its Effects on Markets This week brings one of the most awaited events in finance: the Federal Open Market Committee (FOMC) meeting. Analysts are buzzing with predictions that the Federal Reserve might initiate its first interest rate cut in years. Such a move would have significant implications across various market sectors, especially considering...

Continue Reading